 |
||||
|
|
The Office of Technology Management is in contact with a company who is looking to in- license-exclusively or non-exclusively for research-stage therapeutics for rare genetic and metabolic diseases: The company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company focuses primarily on developing first-to-market therapeutics for rare genetic and metabolic diseases and is currently evaluating opportunities to leverage its expertise to develop therapeutics for more common diseases. Please contact the Office of Technology Management if you have any technology that may be relevant to this request. |
|||
